Company Info
Phone(410) 522-8707
Year Established
2011
Ticker
AVTX
Exchange
NASDAQ
Contacts
Garry Neil, MDChair & CEO
Chris Sullivan
CFO
Paul Varki
CLO
Mittie Doyle, MD, FACR
CMO
Jennifer Riley
Chief Strategy Officer
Company Description
Avalo Therapeutics, formerly Cerecor & Aevi Genomic, is a clinical stage biotechnology company focused on the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network.